Algernon Pharmaceuticalsinc (AGN.CN)
0.0850 x 12000 0.1000 x 10000
Post-market by (Cboe BZX)
0.0900 unch (unch) 03/21/25 [CNSX]
0.0850 x 12000 0.1000 x 10000
Post-market 0.0900 unch (unch) 13:44 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 08/31
| 08-2023 | 05-2023 | 02-2023 | 11-2022 | 08-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 13 | 13 | 13 | 12 | 28 |
| Accounts receivable | -25 | 19 | 121 | 453 | -164 |
| Other Working Capital | 276 | 174 | 377 | 439 | 474 |
| Other Operating Activity | -836 | -939 | -950 | -1,712 | -1,810 |
| Operating Cash Flow | $-573 | $-733 | $-440 | $-807 | $-1,472 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -6 | -27 | -9 | -18 | -49 |
| Investing Cash Flow | $-6 | $-27 | $-9 | $-18 | $-49 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 167 | 1,054 | N/A | N/A | 2,055 |
| Other Financing Activity | 102 | -80 | -17 | 103 | 0 |
| Financing Cash Flow | $269 | $974 | $-17 | $103 | $2,055 |
| Exchange Rate Effect | 0 | 0 | -3 | 3 | 1 |
| Beginning Cash Position | 434 | 221 | 690 | 1,409 | 873 |
| End Cash Position | 125 | 434 | 221 | 690 | 1,409 |
| Net Cash Flow | $-309 | $214 | $-467 | $-722 | $534 |
| Free Cash Flow | |||||
| Operating Cash Flow | -573 | -733 | -440 | -807 | -1,472 |
| Capital Expenditure | -6 | -27 | -9 | -18 | -49 |
| Free Cash Flow | -578 | -760 | -449 | -825 | -1,521 |